Genus (LON:GNS) Releases Earnings Results

Genus (LON:GNS) announced its earnings results on Thursday. The company reported GBX 110.30 EPS for the quarter, Digital Look Earnings reports. Genus had a return on equity of 44.90% and a net margin of 43.35%.

Here are the key takeaways from Genus’ conference call:

• FY 2026 results were strong: adjusted profit before tax and adjusted EPS each rose 35%, while free cash flow increased to £62 million and leverage fell to 0.4x.
• Genus announced a £60 million share buyback for FY 2027 and recommended a 10% increase in the full-year dividend to 35.2 pence per share, reflecting confidence in cash generation and future growth.
• PIC delivered broad-based growth, including 52% royalty-revenue growth in China and market-share gains, while the new China joint venture is expected to support further expansion in the world’s largest porcine market.
• PRP regulatory progress continued with approvals or favorable determinations in Argentina, Canada, Uruguay, and Peru; commercialization is now beginning in selected Latin American markets, although approvals in Mexico and China remain pending.
• Management expects FY 2027 underlying adjusted profit before tax to be only moderately higher, with growth weighted toward the second half due to weak agricultural markets, North American disease pressures, lower Brazilian growth, depressed dairy conditions, and higher PRP and product-development costs.

Genus Stock Up 1.5%

Shares of GNS stock traded up GBX 32 during mid-day trading on Friday, reaching GBX 2,192. 3,602,064 shares of the company were exchanged, compared to its average volume of 785,822. The company has a debt-to-equity ratio of 14.02, a quick ratio of 1.08 and a current ratio of 2.22. The business’s 50 day simple moving average is GBX 2,220.31 and its 200 day simple moving average is GBX 2,374.09. The company has a market capitalization of £1.46 billion, a P/E ratio of 30.87, a P/E/G ratio of 2.87 and a beta of 0.90. Genus has a fifty-two week low of GBX 1,943 and a fifty-two week high of GBX 3,220.

Trending Headlines about Genus

Here are the key news stories impacting Genus this week:

• Positive Sentiment: Genus reported higher FY26 pretax profit, reduced leverage and launched a £60 million share buyback. The repurchase signals management confidence in the company’s long-term growth prospects and could support earnings per share. Genus Launches £60 Mln Share Buyback Programme
• Positive Sentiment: Berenberg reaffirmed its Buy rating and set a GBX 3,350 price target, implying substantial upside from recent trading levels. Genus announces £60m buyback as FY profits rise
• Neutral Sentiment: Genus posted quarterly EPS of GBX 110.30, with a 9.70% return on equity and 7.07% net margin. The results provide evidence of profitability, but the market reaction indicates investors were more concerned about forward guidance and revenue performance. Genus quarterly earnings
• Negative Sentiment: Management forecast moderate FY27 operating-profit growth, while FY26 revenue missed expectations. The combination has raised concerns about slower near-term momentum, outweighing the improved profit, lower debt and buyback news. Genus Shares Fall as Company Forecasts Moderate FY27 Growth

Insider Transactions at Genus

In related news, insider Celia Baxter purchased 2,336 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The shares were purchased at an average cost of GBX 2,140 per share, with a total value of £49,990.40. 0.71% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank restated a “buy” rating and set a GBX 3,350 target price on shares of Genus in a research note on Thursday. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of GBX 3,216.67.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.